| pubmed-article:1331624 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1331624 | lifeskim:mentions | umls-concept:C0034721 | lld:lifeskim |
| pubmed-article:1331624 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:1331624 | lifeskim:mentions | umls-concept:C0014442 | lld:lifeskim |
| pubmed-article:1331624 | lifeskim:mentions | umls-concept:C2709248 | lld:lifeskim |
| pubmed-article:1331624 | lifeskim:mentions | umls-concept:C0003250 | lld:lifeskim |
| pubmed-article:1331624 | lifeskim:mentions | umls-concept:C0678812 | lld:lifeskim |
| pubmed-article:1331624 | lifeskim:mentions | umls-concept:C0175630 | lld:lifeskim |
| pubmed-article:1331624 | lifeskim:mentions | umls-concept:C0205369 | lld:lifeskim |
| pubmed-article:1331624 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
| pubmed-article:1331624 | lifeskim:mentions | umls-concept:C0243144 | lld:lifeskim |
| pubmed-article:1331624 | lifeskim:mentions | umls-concept:C0032172 | lld:lifeskim |
| pubmed-article:1331624 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:1331624 | pubmed:dateCreated | 1992-12-3 | lld:pubmed |
| pubmed-article:1331624 | pubmed:abstractText | The biodistribution of radiolabeled mouse monoclonal antibody (MoAb) to angiotensin-converting enzyme (ACE) and control, nonimmune mouse IgG in platelet activating factor (PAF)-treated rats was studied. The blood level of both preparations was slightly decreased (90% of the control) in PAF-treated rats. Specific pulmonary accumulation of anti-ACE MoAb was reduced to 50% of control in contrast to a doubling in nonspecific pulmonary uptake of non-immune IgG. The changes in anti-ACE MoAb biodistribution were lung-specific and were accompanied by decrease in the pulmonary ACE activity (to 60% of control) and increase in serum ACE activity (to 170% of control). Thus anti-ACE MoAb reveals PAF-induced changes in the status of the pulmonary ACE and therefore can be used for the studies of pathology of the pulmonary endothelium. | lld:pubmed |
| pubmed-article:1331624 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1331624 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1331624 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1331624 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1331624 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1331624 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1331624 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1331624 | pubmed:issn | 0341-2040 | lld:pubmed |
| pubmed-article:1331624 | pubmed:author | pubmed-author:DanilovS MSM | lld:pubmed |
| pubmed-article:1331624 | pubmed:author | pubmed-author:MuzykantovV... | lld:pubmed |
| pubmed-article:1331624 | pubmed:author | pubmed-author:AtochinaE NEN | lld:pubmed |
| pubmed-article:1331624 | pubmed:author | pubmed-author:HiemischH HHH | lld:pubmed |
| pubmed-article:1331624 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1331624 | pubmed:volume | 170 | lld:pubmed |
| pubmed-article:1331624 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1331624 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1331624 | pubmed:pagination | 349-58 | lld:pubmed |
| pubmed-article:1331624 | pubmed:dateRevised | 2003-11-14 | lld:pubmed |
| pubmed-article:1331624 | pubmed:meshHeading | pubmed-meshheading:1331624-... | lld:pubmed |
| pubmed-article:1331624 | pubmed:meshHeading | pubmed-meshheading:1331624-... | lld:pubmed |
| pubmed-article:1331624 | pubmed:meshHeading | pubmed-meshheading:1331624-... | lld:pubmed |
| pubmed-article:1331624 | pubmed:meshHeading | pubmed-meshheading:1331624-... | lld:pubmed |
| pubmed-article:1331624 | pubmed:meshHeading | pubmed-meshheading:1331624-... | lld:pubmed |
| pubmed-article:1331624 | pubmed:meshHeading | pubmed-meshheading:1331624-... | lld:pubmed |
| pubmed-article:1331624 | pubmed:meshHeading | pubmed-meshheading:1331624-... | lld:pubmed |
| pubmed-article:1331624 | pubmed:meshHeading | pubmed-meshheading:1331624-... | lld:pubmed |
| pubmed-article:1331624 | pubmed:meshHeading | pubmed-meshheading:1331624-... | lld:pubmed |
| pubmed-article:1331624 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1331624 | pubmed:articleTitle | Systemic administration of platelet-activating factor in rat reduces specific pulmonary uptake of circulating monoclonal antibody to angiotensin-converting enzyme. | lld:pubmed |
| pubmed-article:1331624 | pubmed:affiliation | Institute of Experimental Cardiology, Moscow, Russia. | lld:pubmed |
| pubmed-article:1331624 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1331624 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1331624 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1331624 | lld:pubmed |
